Related Experiment Video
Updated: Sep 8, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Eutectic Itraconazole and Posaconazole System and the Advantages of Its Use in the Amorphous Form
Justyna Knapik-Kowalczuk1,2, Abu T M Serajuddin2, Paulina Poloczek1
1Institute of Physics, Faculty of Science and Technology, University of Silesia in Katowice, 75 Pułku Piechoty 1A, 41-500Chorzów, Poland.
Abstract:
Itraconazole (ITR) and posaconazole (POS) exhibit closely related molecular structures but differ significantly in their ability to form liquid crystalline (LC) phases. This makes them an attractive model system to investigate how subtle structural differences influence molecular organization in the amorphous state. In this work, we investigate coamorphous systems composed of ITR and POS prepared via melt-quenching, focusing on the interplay between molecular dynamics, physical stability, and LC ordering. Differential scanning calorimetry (DSC) and broadband dielectric spectroscopy (BDS) reveal that the glass transition temperature remains nearly unchanged over a wide compositional range, indicating comparable molecular mobility of all investigated systems. Despite this similarity, a pronounced, nonmonotonic dependence of crystallization kinetics on composition is observed, with a clear stability maximum at the eutectic ratio. Strikingly, this specific composition is also associated with the complete disappearance of the LC ordering characteristic of neat ITR. While ITR-rich mixtures close to the eutectic point still exhibit residual LC transitions, the eutectic composition yields a fully disordered amorphous phase. These results demonstrate, for the first time, that coamorphization at the eutectic composition might suppress LC ordering. The findings highlight the critical role of composition in governing both molecular organization and stability in amorphous pharmaceuticals.
More Related Videos
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
07:12Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions
Published on: July 17, 2020
Related Concept Videos
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Ophthalmic Drug Delivery Systems
Oral Drug Delivery Systems: Delayed-Release Systems
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Oral Drug Delivery Systems: Continuous-Release Systems
Antifungal Agents